Showing results (111-120 of 377) with videos related to

Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Patient and physician decision styles and breast cancer chemotherapy use in older women: Cancer and Leukemia Group B protocol 369901Jeanne S Mandelblatt, Leigh Anne Faul, George Luta, et al.
Therapeutic Advances in Medical Oncology|August 4, 2022
Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancerSonia Pernas, Jennifer L Guerriero, Sergey Naumenko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trialVered Stearns, Rebecca Slack, Nancy Greep, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 14, 2012
Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choiceKristi D Graves, Patti Vegella, Elizabeth A Poggi, et al.
JAMA Oncology|March 21, 2024
PARP Inhibitors for Breast Cancer Treatment: A ReviewStefania Morganti, Antonio Marra, Carmine De Angelis, et al.
Annals of Surgical Oncology|March 20, 2025
Impact of the American Society of Breast Surgeons' Guidelines on Genetic Testing and Contralateral Prophylactic Mastectomy RatesAnna Weiss, Maria Sol Rosito, Danielle Braun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testingKenneth P Tercyak, Beth N Peshkin, Barbara M Brogan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancerVered Stearns, Baljit Singh, Theodore Tsangaris, et al.
Pageof 38